TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD
E. Monso Molas (Sabadell, Spain), K. Opron (Ann Arbor, United States of America), O. Sibila (Barcelona Arbor, Spain), R. Faner (Barcelona Arbor, Spain), T. Gabaldon (Barcelona Arbor, Spain), L. Perea (Barcelona Arbor, Spain), S. Quero (Madrid, Spain), A. Marin (Badalona, Spain), M. Dominguez Alvarez (Barcelona, Spain), M. Garcia Núñez (Sabadell, Spain), Y. Huang (Ann Arbor, United States of America)
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Monso Molas (Sabadell, Spain), K. Opron (Ann Arbor, United States of America), O. Sibila (Barcelona Arbor, Spain), R. Faner (Barcelona Arbor, Spain), T. Gabaldon (Barcelona Arbor, Spain), L. Perea (Barcelona Arbor, Spain), S. Quero (Madrid, Spain), A. Marin (Badalona, Spain), M. Dominguez Alvarez (Barcelona, Spain), M. Garcia Núñez (Sabadell, Spain), Y. Huang (Ann Arbor, United States of America). TREATMENT-RELATED DETERMINANTS OF THE RESPIRATORY MICROBIOME IN COPD. 986
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: